This was made possible because we had the right people on our teams.

Our aspiration is to double our patient reach by year 2022 and raise this by five times more at year end 2025.

Novartis believes that providing the right environment for the right people will help them fully apply their talent and energy to drive our aspiration and create value for the company, our stakeholders and above all the patients whose lives we strive to improve.

This role will be responsible for driving the Marketing Strategy and Portfolio Management and business development in Liberia and Sierra Leone for our new, single, “One Novartis” EWA Cluster.

SSA currently comprises Innovative Medicines (Pharma + Oncology), Sandoz, Global Health & Corporate Responsibility (GH & CR) and Business-enabling Functions. This role will be responsible for establishing, maintaining and implementing an SSA Marketing & Portfolio Strategy and business development in Sierra Leone, Liberia and...